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Hyaluronidases are a family of endolytic glycoside hydrolases
that cleave the 1–4 linkage betweenN-acetylglucosamine and
glucuronic acid in hyaluronan polymers via a substrate-assisted
mechanism. In humans, turnover of hyaluronan by this enzyme
family is critical for normal extracellular matrix remodeling.
However, elevated expression of the Hyal1 isozyme accelerates
tumor growth andmetastatic progression. In this study, we used
structural information, site-directed mutagenesis, and steady
state enzyme kinetics to probe molecular determinants of
human Hyal1 function. Mutagenesis of active site residues
Glu131 andTyr247 toGln andPhe, respectively, eliminated activ-
ity at all hyaluronan concentrations (to 125 M or 2.5 mg/ml).
Conservative mutagenesis of Asp129 and Tyr202 significantly
impaired catalysis by increases of 5- and 10-fold in apparentKm
and reductions in Vmax of 95 and 50%, respectively. Tyr247 and
Asp129 are required for stabilization of the catalytic nucleophile,
which arises as a resonance intermediate of N-acetylglucosa-
mine on the substrate. Glu131 is a likely proton donor for the
hydroxyl leaving group. Tyr202 is a substrate binding determi-
nant. General disulfide reduction had no effect on activity in
solution, but enzymatic deglycosylation reduced Hyal1 activity
in a time-dependent fashion.Mutagenesis identifiedAsn350 gly-
cosylation as the requisite modification. Deletion of the C-ter-
minal epidermal growth factor-like domain, in which Asn350 is
located, also eliminated activity, irrespective of glycosylation.
Collectively, these studies define key components of Hyal1
active site catalysis, and structural factors critical for stability.
Such detailed understanding will allow rational design of
enzyme modulators.
Hyaluronidase family enzymes are broadly expressed across
many diverse species from bacteria tomammals (1, 2). Depend-
ing on the organism, there may be one or several isozymes (3).
In humans, five isozymes have been identified and character-
ized to varying extents for tissue and cellular distribution, acti-
vity profile, substrate specificity and function. Hyaluronidases
have been termed spreading factors because of their potential
to accelerate the spread of toxic venom effects from bees and
snakes (4). Loss of hyaluronidase expression in humans is impli-
cated in dysregulated extracellular matrix turnover and corre-
lates with a type of lysosomal storage disorder called mucopo-
lysaccharidosis IX (5). Increased hyaluronidase activity may be
important for promotion of vascular development during
embryogenesis andwoundhealing, aswell as tumor growth and
metastasis (6–13). Because the hyaluronidase expression level
and/or activation state is thought to determine whether its
effect is to promote or suppress these processes (14), it is critical
to gain a thorough understanding of the molecular determi-
nants of its enzymatic activity.
Human hyaluronidases are glycoside hydrolase enzymes
(Family 56 as described by the carbohydrate-active enzymes
data base at www.cazy.org (15)) characterized by substrate-as-
sisted catalytic mechanism and retention of configuration at
the anomeric carbon subsequent to cleavage of the 1–4 link-
age between the N-acetylglucosamine and glucuronic acid
components of the hyaluronan (HA)2 polymer (1, 16, 17).
Members of this family are endoglycosidases, with homology to
chitinases and lysozyme (18–21). Several of them, including
Hyal1 (22–24), exhibit an acidic activity profile, consistent with
their lysosomal function. Scheme 1 illustrates the proposed
reaction mechanism, indicating specific acidic amino acid res-
idues directly implicated in catalysis by sequence conservation
and homology to the experimentally characterized sperm acro-
somal hyaluronidase, PH-20 (25). Much of the proposed
scheme has been tested in related enzymes, the chitinases (17–
21), because nomolecular characterizations of Hyal1 have been
performed. Briefly, in the resting state at its optimal pH of 4.0,
aspartate 129 and glutamate 131 essentially share a proton.
Catalysis is thought to require initiation by intramolecular res-
onance of the amide bond ofN-acetylglucosamine in the bound
HA polymer. The transition state briefly acquires a positive
charge on the nitrogen, whereas the carbonyl becomes an oxy-
anion nucleophile positioned to attack the electrophilic ano-
meric carbon of the same N-acetylglucosamine unit. As this
intramolecular attack occurs, a five-membered ring forms,
driving out the C4 hydroxyl of the departing, newly cleaved
portion of the chain, which is protonated by Glu131. Transition
state formation is stabilized by the negative charge on Asp129
that is positioned in hydrogen bond distance to the positively
charged substrate nitrogen as Glu131 transfers its proton to the
leaving group. Glu131, thus deprotonated, serves to activate an
incoming water molecule for hydrolysis of the intramolecular
intermediate to restore N-acetylglucosamine. Support for this
mechanism derives from the observation that allosamidin, an* Thisworkwas supported, inwholeor inpart, byNational Institutes ofHealthGrants R01 CA106584 and NCRR P20 RR018759 (to M. A. S.).
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oligosaccharide that terminates in a five-membered ring struc-
ture, is an effective competitive inhibitor of the closely related
chitinase family (21), which cleaves poly-N-acetylglucosamine
and shows conservation of several key active site residues,
including the aspartate and glutamate. Retention of configura-
tion at the anomeric carbon has been shown for a related bac-
terialN-acetylglucosaminidase enzyme (18), and serves to sup-
port existence of an intramolecular transition state. Also
available is a crystal structure of a distantly homologous bacte-
rial hyaluronan lyase with bound ascorbate, a potent five-mem-
bered ring-containing inhibitor of both bacterial lyases and
human hyaluronidases (24, 26).
Recently, the crystal structure for human Hyal1 was deter-
mined (27). Superposition of available crystal coordinates for a
HA tetrameric substrate bound to the bee venom hyaluroni-
dase (4) allowed us to visualize the positions of aspartate and
glutamate in hydrogen bond distance of each other and to pre-
dict their proximity to the HA tetrasaccharide substrate. We
used this structural information, in conjunction with sequence
alignments and comparisons to the bee venom hyaluronidase
structure, to identify putative active site residues and other
structural contributors. A steady state kinetic assay allowed us
to quantitatively assess the effects of site-directedmutagenesis,
disulfide reduction, and N-glycoside removal. These studies
collectively provide insights into the respective roles of these
features in Hyal1 catalysis.
EXPERIMENTAL PROCEDURES
Cell Culture, Materials, and Reagents—22Rv1 human pros-
tate adenocarcinoma cells (28) and HEK293 human embryonic
kidney cells were purchased from ATCC and cultured as
directed by the vendor. The pFlag-CMV-3 vector, anti-FLAG
M2 antibody-conjugated resin, human umbilical cord HA,
Alcian blue, protease inhibitormixture, bovine serum albumin,
tetramethylbenzidine, N-acetyl-D-glucosamine, and 4-(dim-
ethylamino)benzaldehyde were purchased from Sigma.
Sodium hyaluronate (20 kDa) was from Lifecore Biomedical
Inc. (Chaska, MN). Anti-FLAG M2 antibody was purchased
from Stratagene (La Jolla, CA). Transient transfection of 22Rv1
and HEK293 cells used the FuGENE 6 transfection reagent
(Roche Diagnostics) and calcium phosphate precipitation
methods, respectively. Biotinylated HA-binding protein was
from Seikagaku (Associates of Cape Cod, East Falmouth, MA),
Streptomyces hyaluronidase was from EMD Biosciences (San
Diego, CA), protein N-glycosidase (PNGase F) was from New
England Biolabs (Ipswich, MA).
SubstrateModeling and Structure Representation—Wemod-
eled human Hyal1 in complex with bound HA tetrasaccharide
substrate by superimposing coordinates for the published Apis
melliflora hyaluronidase-HA complex (PDB accession 1FCV
(4)) onto the coordinates for human apo-Hyal1 (PDB accession
2PE4 (27)). A ribbon rendering of the model was made with
Chimera (29). To facilitate selection of residues specifically
involved in catalysis, the active site of a modeled complex with
a HA tetrasaccharide was centered upon as depicted in Fig. 1.
Side chains with potential for chemical reactivity within 5 Å of
the cleaved HA glycoside were identified, as well as several
additional residues that lined the groove possibly accommodat-
ing the full substrate. Conservation across human, bovine,
murine, and bee species in sequence alignments of all hyaluron-
idase isozymes was used as an additional criterion to refine our
choice of putative catalytic, substrate binding and structural
residues. Upon determining that removal of N-glycosides neg-
atively impacted activity, we additionally identified three puta-
tive N-glycosylation sites by primary sequence analysis using
NetNGlyc (30), which are largely conserved among humanhya-
luronidases but not broadly across species. The side chains for
residues examined in the study were colored by atom.
Generation and Purification of Hyal1 Point Mutants—For
Hyal1 overexpression, we utilized the pFlag-CMV-3 eukaryotic
vector encoding the preprotrypsin extracellular secretion sig-
nal followed by a FLAG epitope tag fused to the coding
sequence for Hyal1 with the 21-amino acid signal peptide
removed. The preprotrypsin signal peptide ensured abundant
soluble FLAG-tagged Hyal1 secretion to the conditioned cell
culture media of transfectants. Point mutants of Hyal1 were
generated from the wild-type pFlag-Hyal1 construct using the
SCHEME 1
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QuikChange site-directedmutagenesis kit (Stratagene) accord-
ing to the manufacturer’s protocol. Primer sequences used to
create the wild-type construct and specific point mutations are
given in supplemental Table S1 (affected codons are high-
lighted). Coding sequences for D129N, E131Q, Y202F, N216A,
S245A, Y247F, and R265L, N350A, N350tr, and L356tr were
verified by the Genomics Core at the University of
Nebraska-Lincoln.
For initial activity measurements, recombinant plasmids
encoding N-terminal FLAG epitope fusions to Hyal1 and the
point mutants were used to transfect human 22Rv1 prostate
carcinoma cells with FuGENE 6. After 48 h in RPMI containing
1% serum, conditioned media were collected and concentrated
10-fold using Centriplus YM-10 microconcentrators. Protease
inhibitor mixture was added to the final concentrated superna-
tant. Soluble expression of wild-type and mutant Hyal1 was
verified by Western analysis with anti-FLAGM2 antibody.
Wild-type and mutant protein used for measurement of
kinetic constants and evaluation of post-translational modifi-
cations was purified from conditionedmedia of HEK293 trans-
fectants, with the exception of the N350A, N350tr, and L356tr
mutants, which were purified from the soluble fraction of
HEK293 cell lysates. Media were harvested 48 h after calcium
phosphate transfection, concentrated at least 10-fold, and dia-
lyzed exhaustively against 1Tris-buffered saline before apply-
ing to anti-FLAG affinity resin. After washing with 10 column
volumes of Tris-buffered saline, Hyal1-FLAG was eluted from
the column with FLAG peptide and dialyzed against hyaluron-
idase assay buffer (50 mM sodium formate, pH 4.0, 150 mM
NaCl). Folded structure of mutants that lacked activity was
implied by soluble secretion, but also by their intrinsic trypto-
phan fluorescence profiles (31), whichwere identical to those of
wild-type Hyal1, and red-shifted comparably upon denatur-
ation with 3 M guanidine-HCl (supplemental Fig. S1).
Evaluation of Post-translational Modifications—To evaluate
the importance of disulfides, purified Hyal1 was incubated in
the absence or presence of 1, 10, or 50mMDTT, or 5mM-mer-
captoethanol, for 1 h at 37 °C prior to activity analysis. The
importance of N-glycosides to Hyal1 activity was examined by
enzymatic removal. Purified Hyal1 (16 g) was incubated with
10 units of PNGase F, which is specific for protein N-glycoside
digestion, in the vendor’s recommended buffer (50 mM sodium
phosphate, pH 7.5, 1% Nonidet P-40) for the indicated times
prior to Western blot and kinetic assay.
Hyaluronidase Activity Assays—Hyal1 activity wasmeasured
by one of threemethods. Substrate gel electrophoresis was per-
formed essentially as previously described (32). Concentrated
conditioned media were electrophoresed by SDS-PAGE on a
10% polyacrylamide gel containing 0.2 mg/ml HA. After a 1-h
renaturation in 3% Triton X-100, gels were incubated in hyalu-
ronidase assay buffer at 37 °C overnight, stained with 0.5%
Alcian blue for at least 2 h, and destained with 7% acetic acid.
Initial quantitative comparisons of wild-type and mutant
Hyal1 activity were done in anHA-coatedmicroplate assay (13,
32–34). Briefly, serial dilutions of concentrated conditioned
media adjusted for equal Hyal1 content were applied in tripli-
cate to 96-well plates that had been precoated overnight at 4 °C
in a solution of 50 g/ml human umbilical cord HA (200 mM
carbonate buffer, pH 9.6), and blocked with Pierce Superblock
reagent. After a 1-h incubation in hyaluronidase assay buffer,
wells were washed and residual HA was detected by biotiny-
lated HABP, detected with avidin-biotin horseradish peroxi-
dase and tetramethylbenzidine substrate. Absorbance at 650
nm was used to interpolate specific activity from a concurrent
Streptomyces hyaluronidase standard curve.
Activity of wild-type and all mutant Hyal1 species was
assayed as previously described by Reissig et al. (36). Purified
enzyme (0.5 g) was incubated with increasing concentrations
of HA (20 kDa) in hyaluronidase assay buffer containing 0.1%
bovine serum albumin. The reaction was heat inactivated
(100 °C for 5 min). Cleaved ends were quantified by the Mor-
gan-Elson color reaction (potassium tetrahydroborate and
acidified dimethylamino benzaldehyde) and absorbance at 585
nm. Molar quantity of N-acetylglucosamine reducing ends in
each sample was interpolated from a concurrently developed
standard of N-acetyl-D-glucosamine. An initial time course
revealed linear kinetics for wild-type Hyal1 from 10 to 90 min,
so a time point of 60 min was chosen for all subsequent assays.
Michaelis constants (Km and Vmax) were determined for Hyal1
species that exhibited saturable kinetics by fitting data to a
model of single site association using Prism (GraphPad Soft-
ware Inc., La Jolla, CA). Heterogeneous viscosity of the HA
solutions increased above 125 M (2.5 mg/ml), so this was the
maximum concentration assayed. Thus, Km and Vmax values
were extrapolated from the curve fit where indicated.
RESULTS
Examination of the Hyal1 Active Site—Our goal in this study
was to probe the molecular interactions that specify hyaluron-
idase activity of human Hyal1. To obtain sufficient protein
quantities, we overexpressed the enzyme as a secretedN-termi-
nal FLAG epitope fusion. Because a significant aspect of
research onHyal1 is focused in the context of human cancer, we
initially used 22Rv1, a humanprostate adenocarcinoma cell line
model for prostate cancer progression, as the host line for pro-
tein production. These cells normally produce little active hya-
luronidase (13), and overexpression of Hyal1 was found to
accelerate their growth in culture as well as their metastatic
dissemination to lymph nodes in mouse orthotopic tumor
models (6, 37). Abundant soluble FLAG-tagged Hyal1 was
secreted to the conditioned cell culture media of transfectants.
The first round of mutagenesis was directed at characteriza-
tion of the putative enzyme active site. Using crystal coordi-
nates for the bee venom hyaluronidase complexed with HA (4),
in conjunction with human apo-Hyal1 coordinates (27), we
depicted the human enzyme bound to a tetrasaccharide sub-
strate, and inspected the architecture of the active site (Fig. 1).
Based on this model, we identified specific residues within 5 Å
of the cleaved HA product in the active site, as likely to be
important for catalytic activity. We further selected several
amino acids that lined a groove capable of accommodating a
full-length HA polymer prior to cleavage. Accordingly, point
mutations were generated at residues Asp129, Glu131, Tyr202,
Asn216, Tyr247, Ser245, andArg265 to investigate their individual
contributions to the enzyme mechanism. Fig. 1 illustrates the
positions of these residues in the active site of human Hyal1
Catalytic Residues of HumanHyal1
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relative to HA. Substrate-proximal residues fell into three re-
gions: residues still in contact with the residual tetrasaccha-
ride that can be presumed involved in binding and substrate
recognition; residues in non-covalent bond distance from the
newly cleaved end of the substrate, including Asp129 and
Glu131, that are obvious candidates for direct catalytic roles;
and residues proximal to the cleav-
age point of the substrate that were
likely to have been in contact with a
transition state and/or the released
portion of the cleaved HA chain,
such as Tyr202 and Tyr247. Analogy
to point mutations in both sperm
hyaluronidase, PH-20 (25), and bac-
terial N-acetylglucosaminidase H
(20), further suggested Asp129 and
Glu131 would be critical for catalytic
activity of the enzyme. Arg265 has
previously been predicted to be
important for substrate binding.
Asn216 is a putative N-glycosylation
site and its placement within the
substrate groove led us to test its
importance for enzyme activity
and/or substrate binding. The roles
of the serine and tyrosine residues
have not been examined in any
hyaluronidases.
Wild-type and all Hyal1 point
mutants were expressed and
secreted to conditioned media (Fig.
2A). Initial characterization of
enzyme activities was performed at
a single HA concentration in HA-
coated microwell plates, using con-
centrated culturemedia from trans-
fected tumor cells (Fig. 2B). Results
of these assays demonstrated negli-
gible activity for the E131Q mutant
(0.11  0.01 units/ml of culture
media per mg of Hyal1), similar to
the vector-transfected control
media (NC, 0.07  0.01 units/ml/
mg). This value is 0.26  0.03% of
wild-type Hyal1 activity. Catalytic
function was also significantly
diminished by D129N mutagenesis
(1.4 0.3% of wild-type activity), as
well as Y202F (5.6  1.4%), Y247F
(4.8  0.7%), and R265L (1.4 
0.6%). S245A retained 36  6% of
normal activity, whereas N216A
had no effect. The relative effects on
activity were also observed when
soluble lysates from the respective
transfectants were assayed in the
microplate format (data not shown).
Thus, the acidic and tyrosine resi-
dues, as well as serine 245 and arginine 265, appeared to have
prominent roles in the hyaluronidase activity of Hyal1. To
address the specific functions of individual residues more rig-
orously, we subsequently purified each Hyal1 species from
HEK293 transfectantmedia, because these cells weremore eas-
ily transfected and yielded greater protein quantities.
FIGURE 1. Ribbon representation of the human Hyal1 crystal structure with bound HA tetrasaccha-
ride. Crystal coordinates from the HA substrate crystallized in the bee venom hyaluronidase structure
(PDB code 1FCV) were used to place an HA tetrasaccharide in stick representation at the active site groove
of human Hyal1 (PDB code 2PE4). A, side chains of residues examined in this study for potential catalytic
importance are labeled and shown in stick representations. One active site proximal disulfide is indicated
(Cys207–Cys221), as well as the three asparagines that are sites for N-glycosylation (Asn99, Asn216, and
Asn350), shownmodifiedwith short carbohydrate chains as determined in the crystal structure. Themolec-
ular interactions occurring between bound HA and putative catalytic residues at the active site are
depicted in an active site magnification (B), with hydrogen bonds indicated by thin black lines. Carbon
atoms of the protein residues and modifications are represented in gray, whereas those of the substrate
are in green. In both cases, nitrogen atoms are blue, oxygen are red, and sulfurs are yellow. GlcA, glucuronic
acid; NAG, N-acetylglucosamine.
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Glutamate 131 and Tyrosine 247 Are Essential Catalytic
Residues—For kinetic analyses, we measured Hyal1 activity by
the method of Reissig et al. (36), in which cleavage events are
quantified by the reaction of liberated N-acetylglucosamine
ends with a colorimetric substrate. Activity of the wild-type
enzyme was saturable with increasing substrate concentration
(Fig. 3A). Apparent kinetic constants Km and Vmax were calcu-
lated by non-linear curve fitting of the data to an equation for
single site association, considering all HA substrate and prod-
uct sizes equally (Table 1). Activity values for eachmutant at the
50 M coating concentration used in the microplate assay were
also compared with those of the wild-type enzyme. Analysis of
E131Q kinetics revealed no significant activity at any HA con-
centration tested, even with 5-fold more enzyme added (Fig.
3B). This is consistent with results from the analogous PH-20
hyaluronidase mutant assayed by agarose gel electrophoresis
(25) and with the above microplate assay. Although several of
the mutants (i.e. D129N and Y202F, Fig. 3C, discussed below)
showed clear dependence of activity on substrate concentra-
tion, E131Q did not. Identical results were observed with the
Y247F mutant (Fig. 3D). Absence of activity at all substrate
concentrations indicatesGlu131 andTyr247 have critical roles in
the catalytic mechanism.
Aspartate 129 Directly Supports Catalysis, Whereas Tyrosine
202 and Serine 245 Are Substrate Binding Determinants—In
addition to Glu131, Asp129 was also predicted to be an essential
catalytic residue. Mutagenesis of this residue to the isosteric
asparagine significantly reduced Vmax and increased Km nearly
5-fold (Fig. 3C and Table 1). Interestingly, Asp129 was not
essential, because significant activity was retained. Detrimental
effects specifically resulting from loss of its acidic character
suggest a direct catalytic function, whereas change inKm impli-
cates Asp129 additionally in HA binding. Based on their respec-
tive positions, Tyr202 and Ser245 were predicted to position the
substrate acetamido group for attack on the anomeric carbon.
Kinetic analysis showed that Y202F reduced but did not elimi-
nate enzyme activity (Fig. 3C). However, its clear role in hydro-
gen bond coordination of the substrate and placement of other
residues at the active site is reflected
in the Km for substrate that is
increased 10-fold relative to that
of the wild-type enzyme. Catalysis
by S245A is unaltered with respect
to Vmax, but this mutant has lower
affinity for HA as indicated by the
3-fold higher Km (Fig. 3A and
Table 1). Thus, the importance of
Ser245 at the enzyme active site is to
ensure substrate binding. Collec-
tively, these conserved residues are
important for maximal catalytic
efficiency, although they are not
essential for function.
Alteration of Arginine 265 Per-
turbs Active Site Architecture—Ki-
netic analysis of the R265L mutant
confirmed a significant reduction in
enzyme activity, as observed in the
microplate assay (Table 1). In fact,
this mutation was as disruptive as
D129N, retaining only4% of wild-
type activity at 50 M HA (Table 1).
However, dependence of activity on
HA concentration was approxi-
mately linear over the range tested
and did not approach saturation, so
FIGURE 2. Conservative mutagenesis of specific acidic and tyrosine resi-
dues significantly reduces Hyal1 activity. The indicated mutations were
introduced to thewild-typepFlag-Hyal1 construct asdescribedunder “Exper-
imental Procedures.” Conditioned media were prepared from 22Rv1 human
prostate tumor cells transfectedwith the respective constructs. A, equivalent
protein amounts, as determined by Bio-Rad assay, were analyzed byWestern
blot probedwith anti-FLAGantibody to comparewild-typeandmutantHyal1
expression. B, hyaluronidase activity of the conditionedmediawas assayed in
aquantitativemicroplate assay.Densitometricmeasurements fromtheWest-
ern blot in A were used to normalize wild-type and mutant Hyal1 content.
Equal amounts of the indicated Hyal1 species were serially diluted and
applied in triplicate toHAprecoatedmicrowell plates. Residual HAwas quan-
tified to obtain specific activities. Values represent the mean S.E.
FIGURE3.Kinetic analysisofwild-typeandmutantHyal1 reveals the importanceofactive site residues in
substrate affinity as well as catalysis. Purified protein was incubated for 60 min with the indicated concen-
trations of sodium hyaluronate (HA, 20 kDa) before quantification of cleavage events by Morgan-Elson color
reaction as described under “Experimental Procedures.” Data were fitted to an equation for single site associ-
ation andused to calculate specific activities,Vmax andMichaelis constants aspresented in Table 1.MeanS.D.
of triplicate determinations for eachHA concentrationwere plottedwith the curve fit. Results for Hyal1 species
that exhibited saturable kinetics in the conditions evaluated are shown: A, Hyal1 wild-type (WT) and S245A
point mutant (0.5g of enzyme assayed); C, Y202F and D129N (2.5g of enzyme), plotted on a different scale
to illustrate saturability; B, E131Q, and D, Y247F had negligible activity at all HA concentrations (2.5 g of
enzyme).
Catalytic Residues of HumanHyal1
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we were unable to determine kinetic constants for this mutant.
At the maximum HA concentration of 125 M (2.5 mg/ml),
activity was 0.67  0.02 mol/min/mg, which was 7.3% of the
wild-type enzyme activity at this amount. Thus, catalytic func-
tionwas impairedwithin this range ofHAconcentrations, but it
was not possible to predict whether Vmax was altered.
Disulfide Stabilization Is Not Critical for Activity—The
Hyal1 enzyme contains five disulfide bonds, three of which are
located in a C-terminal EGF-like domain remote from the
enzyme active site. However, one disulfide bond occurs
between Cys207 and Cys221, both adjacent to the putative sub-
strate binding groove. This disulfide appears to be required for
stabilization of a loop containing the Asn216 glycosylation site
(Fig. 1A). Disulfides have been suggested to have importance in
the function of PH-20 (38), but their role has not been tested
extensively. To test the significance of disulfides for activity of
Hyal1, we treated affinity purified protein with the disulfide
reducing agentDTT, and evaluated its resulting activity (Fig. 4).
Both conditionedmedia and FLAG-affinity purifiedHyal1 con-
tained abundant protein activity. Interestingly, this activity was
completely eliminated in a HA substrate gel assay (Fig. 4B),
whereas no effects were observed in themicroplate format (Fig.
4C), unless the enzyme was first heat-inactivated. Kinetic anal-
ysis revealed identical saturation and Michaelis constants for
concentration dependence of specific activity (Fig. 4D), consist-
ent with results of the microplate assay. Furthermore, satura-
tion curves and kinetic constants were not affected at any con-
centration ofDTT (1, 10, or 100mM), nor by preincubationwith
5 mM -mercaptoethanol (data not shown). Thus, disulfides
probably affect folding of the enzyme and long term stability in
the acidic environment of the lysosome, but the folded Hyal1
active site does not intrinsically appear to require disulfide
bonds for its optimal conformation.
Deglycosylation of Hyal1 or Mutagenesis of Asparagine 350
Eliminates Activity—In studies of the PH-20 isozyme, deglyco-
sylationwas found to reduce hyaluronidase activity in substrate
gel assays (38). Three canonical N-glycosylation sites are pres-
ent in Hyal1. To test their importance, N-glycosyl moieties
were digested from purified Hyal1 and activity was assayed rel-
ative to extent of glycosylation. Removal of glycosideswasmon-
itored concurrently byWestern blot (Fig. 5A). Significant diges-
tion of glycosides was already evident at 0 h as a shift in
molecularmasses from amajor52-kDa band in the untreated
sample, presumably corresponding to the fully glycosylated
species, to a series of 4 bandswithin the first 5min after PNGase
F addition. Despite this apparent shift, theHAdependent activ-
ity curve at this time point was superimposable for untreated
and treated samples (Fig. 5A and data not shown). The 52-kDa
band was virtually absent by 2 h and no longer visible at 4 h,
replaced by a doublet of42 and45 kDa in the treated sam-
ples. Longer digestion times did not alter this pattern. Kinetic
analysis showed Hyal1 activity decreased in a time dependent
fashion with deglycosylation (Fig. 5A), with apparent Vmax val-
ues only 57, 12, and 1.3% of the untreated Vmax at 1, 2, and 4 h,
respectively.
To confirm the importance of the glycosyl moieties in Hyal1
catalytic function, we mutagenized two of the N-glycosylation
sites. One, Asn216, was located in the disulfide-positioned loop
that forms part of the extended active site, and the other,
Asn350, was located in the C-terminal EGF-like domain. Con-
sistent with the non-essential role of disulfide loop positioning
in catalysis, theN216Amutantwasmaximally active in both the
microplate assay (Fig. 2B) and kinetic analysis (Fig. 5B),
although itsKm forHAwas increased3-fold.N-Glycosylation
FIGURE 4. Disulfide bonds are important for the stability but not the
activity of intact Hyal1. FLAG affinity purified Hyal1 (wild-type) was incu-
bated in the absence or presence of 1 mM DTT prior to Western blotting (A),
HA substrate gel analysis (B), or quantification of activity by microplate assay
(C) and kinetic analysis (D), as described under “Experimental Procedures”.
Lanes in A contain: 1) Hyal1 conditioned media; 2) anti-FLAG affinity column
flow-through; and 3) eluted Hyal1. In B, lane 1 contains Hyal1 transfectant-
conditioned media; lanes 2 and 3 contain purified Hyal1 with and without 1
mM DTT, respectively. Data plotted are the mean S.E. (C) and mean S.D.
(D) of triplicate determinations. D, the concentration dependence of specific
activity was fitted to an equation for single site association. Curve fits are
superimposed as indicated for assays in the continuous absence or presence
of 1 mM DTT following the initial preincubation period. IB, immunoblot.
TABLE 1
Summary of Hyal1 wild-type (WT) andmutant kinetic constants
Enzyme Km Vmax %WT activityat 50 M HA
M mol/min/mg
Hyal1 wild-type 38.1 4.8 12.5 0.7 100.0 1.8
Catalytic mutants
E131Q NAa NA 0.08 0.01
Y247F NA NA 0.04 0.01
D129N 181 19b 1.9 0.1b 5.10 0.09
Substrate binding mutants
Y202F 367 37b 6.7 0.5b 11.1 0.0
S245A 110 19 10.7 1.1 41.1 0.4
Putative structural mutants
R265L NSc NS 4.18 0.09
N216A 103 14 10.0 0.8 44.6 1.3
N350A NS NS 0.12 0.01
N350tr NS NS 2.49 0.17d
L356tr NS NS 6.29 1.50d
aNA indicates no measurable activity at any HA concentration.
b Indicates extrapolated value from saturable curve fit.
cNS, not saturable, indicates data do not fit a saturation curve.
d Values measured at 125 M HA.
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at position 216 was not required for expression or extracellular
secretion of the enzyme (Fig. 2A), but the N216A mutant was
observed as a doublet of 52 and 48 kDa in some prepara-
tions (Fig. 5B), suggesting variable glycosylation. In contrast,
the N350Amutant was expressed only in the soluble cell lysate
as a species of48 kDa. The wild-type protein was consistently
observed in both media and lysate as a 52-kDa band. Kinetic
analysis of the wild-type enzyme affinity purified from the
lysate produced activity curves identical to those of Hyal1
from conditioned media (data not shown), but the lysate-
purified N350A mutant exhibited negligible activity at any
HA concentration tested (0.1% of wild-type at 50 M,
Table 1 and Fig. 5B).
Deletion of the EGF-like Domain Abolishes Hyal1 Activity
Independently of Asparagine 350—The C-terminal EGF-like
domain is not found in the bacterial or bee venom hyaluroni-
dases, so previousmodels ofHyal1 using coordinates for the bee
venom ortholog depicted this region as an independently
folded domain withminimal contacts to the active site contain-
ing domain. Inspection of the human Hyal1 model reveals a
single overall folded domain, with extensive contacts between
the EGF-like region, the sugar moieties of the Asn350 glycosyl
adduct housed within that region, and the remainder of the
protein. We introduced stop codons at position 350 (N350tr),
which deleted 86 amino acids, including the Asn350 glycosyla-
tion site, and at position 356 (L356tr), which deleted the 80-
amino acid EGF-like domain but retained Asn350. Neither dele-
tion mutant was secreted to the extracellular space but both
were expressed well in the soluble lysate (Fig. 5C). Western
blot showed the N350tr lysates contained a major band of
38 kDa, the predicted molecular mass for the polypeptide,
whereas the major band in L356tr lysates was42 kDa, con-
sistent with the 4-kDa shift observed for the fully glycosy-
lated wild-type enzyme. The lysates showed2.5 and6.3%
of wild-type activity for N350tr and L356tr, respectively, at
the 125 M HA amount. Thus, loss of this domain is delete-
rious to both secretion and activity of Hyal1, although the
residual activity suggests the effect is indirect.
DISCUSSION
Hyaluronidase enzymes, most extensively Hyal1, have been
implicated in normal and pathological extracellular matrix
turnover. Crystallographic studies have illuminated the Hyal1
structure (27) and investigation of the wild-type enzyme puri-
FIGURE 5. Glycosylation of asparagine 350 is essential for enzyme activ-
ity. A, purified Hyal1 (wild-type) was incubated in the absence or presence of
PNGase F for 0, 1, 2, or 4 h prior to analysis by Western blot probed with
anti-FLAG antibody (upper panel) and kinetic assay. Mean S.D. and curves
fitted to a single site association are shown from triplicate determinations.
B, site-specific mutations weremade to eliminate two of the threeN-glycosy-
lation sites inHyal1. Purifiedproteinwas comparedwithwild-type inWestern
blots probedwith anti-FLAG (upper panel).MWdenotes themolecularweight
ladder; the band is 52 kDa. The N216A mutant was purified from the condi-
tionedmedia and kinetic parameters determined exactly as for the wild-type
enzyme. TheN350Amutantwas expressed solubly butwas not secreted, so it
was purified from the soluble HEK293 cell lysate and used in 5-fold excess for
kinetic assay. Mean  S.D. and curves fitted to a single site association are
shown from triplicate determinations. C, stop codons were introduced by
site-directed mutagenesis of the Hyal1 coding sequence, to generate C-ter-
minal truncations that eliminated the EGF-like domain at (N350tr) or after
(L356tr) the Asn350 glycosylation site. Western analysis of soluble HEK293 cell
lysates fromvector (NC), Hyal1wild-type (WT), and two separate transfections
each of N350tr and L356tr are shown in the upper panel. Protein was purified
fromeach lysate and assayed for specific activity at a single HA concentration
(125M, HA 20 kDa) using theMorgan-Elson color reaction. Activity of each is
plotted relative to that of wild-type Hyal1.
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fied from insect cells demonstrated its minimum octasaccha-
ride substrate requirement (22). Several naturally occurring
inhibitors have been reported, but rational design of high affin-
ity and/or mechanism-based inhibitors to control disease pro-
gression requires detailed characterization of Hyal1 chemistry.
In particular, specific molecular features conferring enzymatic
properties to Hyal1 have not been previously examined. In this
report, we confirmed the presumed catalytic roles of two active
site residues, identified three additional catalytic components,
and characterized several structurally stabilizing features,
including the intriguing EGF-like domain.
Typically, hyaluronidase activity has been measured at a sin-
gle time point and HA concentration. This is useful for detec-
tion of small amounts of enzyme in complex mixtures. How-
ever, this activity represents a maximum saturation level and
cannot be used to compare quantitatively among hyaluroni-
dases. To establish a system for detailed kinetic analysis, it was
first necessary to generate large scale expression and purifica-
tion schemes.ActiveHyal1 had beenproduced previously using
insect cell expression systems (22–24), but the sugar content of
glycosyl moieties is often not accurately reproduced by insects
relative to the human sequences. Because both PH-20 and
Hyal1 hyaluronidases have shown sensitivity to glycosylation,
the nature of these modifications has the potential to impact
enzymatic function. As an alternative, we expressed wild-type
and mutant human Hyal1 with a FLAG epitope tag and immu-
noaffinity purified the resulting protein from the conditioned
media of either human prostate carcinoma cells or embryonic
kidney cells. Michaelis-Menten kinetic values were not previ-
ously determined for Hyal1 but specific activity reported at a
given concentration (22, 24) is within an order of magnitude of
the values we report here. Using the octasaccharide substrate,
saturation was essentially observed within the same range we
utilized (22), adjusted for the 10-fold difference in molar mass
of the 2-kDa octasaccharide versus the 20-kDa polymeric HA
substrate. The somewhat lower activity of Hyal1 purified from
insect cells relative to the enzyme we have prepared from
human cell culture may be due either to differences in utiliza-
tion of these substrate sizes or in glycosylation.
In studies of PH-20, the residual activity of the analogous
mutation to D129N, absent in E131Q, was interpreted in favor
of an essential direct role in chemical catalysis for Glu131, and a
supporting role in transition state stabilization for Asp129 (2,
25). It is clear that the acidic character of the residue is critical in
both cases. This observation is also consistent with the mecha-
nism illustrated in Scheme 1, inwhich protonatedGlu131 serves
as a general acid for proton transfer to the hydroxyl leaving
group upon glycosidic cleavage. The optimal pH of the enzyme
of4.0 is close to the pKa for the -carboxylate of free glutamic
acid, which supports its ability to serve subsequently as a gen-
eral base to deprotonate and activate incoming water for
hydrolysis. Glutamine lacks dissociable protons and is there-
fore incapable of substituting as a general acid/base. During
catalysis, the substrate acetamido group becomes polarized for
nucleophilic attack at the anomeric carbon, developing a posi-
tive charge on the amide nitrogen while forming the oxyanion
nucleophile. Asp129 must preserve its negative charge to facili-
tate polarization by neutralizing the positive charge on the
nitrogen.
Tyr247 was also an essential residue in our analysis. Place-
ment of Tyr247 in the structural model suggests its role is to
coordinate and stabilize the oxyanion during transition state
formation: the hydroxyl of Tyr247 is optimally located for
hydrogen bond donation to the carbonyl oxygen. An inert role
in binding is less likely, because the Y247F mutation preserves
the hydrophobic character of the residue that is thought to be
important for association with sugar rings in the substrate.
Structural inspection predicts Ser245 does not contact the sub-
strate directly but that the side chain hydroxyl would be an
essential linchpin between Tyr202 and Tyr247, forming a hydro-
gen bond with the hydroxyl of Tyr202 and the pi cloud of Tyr247
and thereby positioning them both. This is consistent with the
comparable Vmax but reduced apparent substrate binding of
both the Y202F and S245A mutants.
The Arg265 guanidino forms a salt bridge with the side chain
carboxylate of Asp206 in the crystal structure of human Hyal1.
Interestingly, this interaction bridges two strands of “unstruc-
tured” coil that shape the active site of the enzyme.One of these
strands, containing Asp206, positions Tyr202 optimally for bind-
ing to the substrate during catalysis. The other strand orients
Ser245 and the essential Tyr247, exact placement of which is
critical for transition state formation. Thus, instead of implicat-
ing the arginine directly in substrate binding via salt bridging
with the carboxylate moieties, as was previously postulated for
an analogous mutation in PH-20, the R265L mutation in Hyal1
shows its importance for structural integrity. Themagnitude of
its effect on catalysis also suggests the shape and rigidity of the
active site cavity is critical to its function, regardless of the pres-
ence of specific catalytic residues.
Despite the essential interaction of Asp206 with Arg265 in
active site architecture, a disulfide between Cys207 and Cys221,
which holds the coil strand containing Asp206 and Tyr202 in
contact with the next adjacent coiled strand to form a loopwith
Asn216 at the apex, is apparently not required forHyal1 activity.
This loop may be stabilized by other interactions and/or not
directly involved in substrate binding or catalysis. Furthermore,
because this loop is the most remote of the contiguous second-
ary backbone elements that form the active site crevice, it may
have the most structural and conformational fluidity. This
would be consistent with the relatively high mobility in the
structure of this region. It is interesting to find that disulfides in
general are only essential for hyaluronidase activity in substrate
gel assays. One major difference between this assay format and
the microplate or Morgan-Elson color reaction formats is that
the proteins are first denatured by SDS and immobilized in an
acrylamide matrix for the substrate gel, presumably limiting
their conformational mobility, whereas native, soluble pro-
tein is analyzed in the quantitative assays. This result sug-
gests that disulfides assist the adoption of native folded
structure and are essential to the partial refolding that allows
hyaluronidase to function upon renaturation by removal of
SDS from the substrate gel. Because the native structure is
not disrupted in microplates, disulfides are not required for
short term folded structures and therefore appear irrelevant
to protein activity.
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Prior studies of Hyal1 and PH-20 revealed reduced activity in
solution and substrate gel assays, respectively, upon partial
enzymatic removal ofN-glycosides (24, 38).However, complete
digestion was not achieved. The results reported here provide
the first direct temporal link between the kinetics of deglycosy-
lation and the loss of hyaluronidase activity. In addition, this
analysis has shown definitively that Hyal1 lacks activity in the
absence of glycosylation, whether resulting from glycoside
removal post-purification or from expression as a pointmutant
incapable of being glycosylated at a specific residue. We were
able to follow glycoside removal by changes in the molecular
mass of Hyal1 by Western blot, in which an apparent 52-kDa
band in untreated samples was presumed to be fully glycosy-
lated, whereas a shift to two bands of 42 and 45 kDa was
consistently the end product of PNGase treatment and likely is
fully deglycosylated. Two bands may indicate that one species
retains the 22-amino acid signal peptide and the other has had
it cleaved. The fourth band seen in significant quantity is an
intermediate species that appears in theN216A lysate and is the
identical size of the N350Amutant, thus this is probably degly-
cosylated only at position 350. Because the N350A mutant
completely lacked activity, deglycosylation at Asn350 is proba-
bly the most detrimental to activity.
Lysosomal enzymes are commonly glycosylated (39), pre-
sumably to protect the protein in the acidic environment of this
compartment, conditions under which Hyal1 is optimally
active. The region of Hyal1 that contains Asn350 is relatively
mobile as indicated by the crystallographic data, but extensive
contact between the sugar modifications and the secondary
structural elements may be important for maintaining stability
of the overall folded structure of the protein indirectly. The
possibility exists that glycosyl adducts could facilitate catalysis
directly by promoting association with the polymeric HA sub-
strate and increasing affinity. However, the kinetic analysis
showed that activity of deglycosylated Hyal1 at all time points
was still saturable with increasing substrate concentration, but
thatVmax was reduced. If glycosylation state only affected affin-
ity, maximal rate of catalysis would not be expected to change.
Asn350 was modeled in the structure with a hexasaccharide
adduct that was fitted to visible electron density, which further
supports its primary role in structural integrity relative to the
other glycosylation sites. No electron density was present for
Asn216 modification so either this residue is not modified or
high mobility in this region obscures additional atoms from
view. Support for Asn216 modification derives from the obser-
vation that the N216Amutant is partly secreted and active, but
intracellularly about 50% of the protein is a species that lacks
the4-kDa adduct, such that it is the same size as N350A on a
Western blot. Thus, glycosylation at positionAsn216may not be
extensive but may facilitate folding and maturation. The side
chain of Asn216 is modeled as oriented to the solvent accessible
surface of the enzyme, with no obvious requisite interactions,
but it may nonetheless interact with HA itself, which would
explain the difference in Km between wild-type and N216A
Hyal1. Asn99 is modeled with two sugar adducts. This highly
mobile region is directed outward and remote from the active
site andmay be less structurally critical, perhaps lacking exten-
sive contact within the main domain.
It has been proposed that the C-terminal EGF-like domain,
found in several reported splice variants of Hyal1, may be the
site of as yet undefined protein-protein interactions (27). The
results presented here suggest that such interactions would
have to occur specifically with the solvent-exposed surface of
the domain, because the inactivity of the truncatedmutants and
their inability to be secreted imply that this region does not
function as an independently folded domain. Its homology to
EGF may be a coincidental folding motif. However, numerous
extracellular matrix proteins, such as laminin, that bear similar
domains have been shown to activate EGF-type signaling
although they do not compete directly with EGF for cell surface
binding (35).
The analysis of Hyal1 point mutants highlights the impor-
tance of specific conserved residues in catalytic function, but
also identifies active site conformation as a critical factor. Dis-
rupted activity resulted from the R265L mutation but not from
N216A or global disulfide reduction. Because each of these per-
turbations has the potential to impact structural integrity of the
enzyme and each is located in positions of potential direct con-
tact with bound substrates, the differences suggest areas of
lesser or greater mobility within the protein may be important
for the accommodation of diverse HA substrate sizes. Inspec-
tion of the Hyal1 solvent-accessible surface according to its
crystal mobility reveals an N-terminal domain encompassing
residues from Pro62 to Pro205 that displays higher collective
structural mobility. This suggests that the N-terminal portion
may move as an entity relative to the remainder of the protein,
like a closing finger and thumb. The thumb appears to be the
similarly mobile loop containing Asn216. Together the closing
appendages may regulate clasping of polymeric HA substrates
and release of cleaved products. In contrast, residues in the
active site groove, and the hydrophobic folded core of the pro-
tein, exhibit the least mobility. At least two residues partially
obscure the substrate solvent accessibility and are among the
residues with the least motion. One of these is a tryptophan
(residue 321) that makes van derWaals contact with the bound
carbon rings and the other is Tyr247, which interacts with the
acetamide of the newly cleaved substrate. This is consistent
with a well defined active site conformation that constrains the
bound ligand for catalysis, whereas the mobile regions allow
promiscuity in polymeric length of the substrate.
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Supplementary figure 1. Intrinsic tryptophan fluorescence of native and denatured Hyal1. 
Purified Hyal1 wild-type (WT) and each of the inactive point mutants was evaluated for 
structural integrity by fluorescence scanning following tryptophan excitation at 295 nm. Spectra 
were collected on 50 nM protein in a buffer of 50 mM tris-HCl, pH 7.0, and 150 mM NaCl in the 
absence (native) or presence (denatured) of 3M guanidine-HCl as indicated. All spectra were 
recorded following a 3 min incubation at room temperature. 
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Supplemental Table 1. Primer sequences for Hyal1 site-directed mutagenesis 
Primer Label Primer Sequence 
Hy1wt Forward TGACAAGCTTTTTAGGGGCCCCTTGC 
Hy1wt Reverse CTGAGAATTCTCACCACATGCTCTTC 
D129N Forward GGGCTGGCAGTCATCAACTGGGAGGCATGGC 
D129N Reverse GCCATGCCTCCCAGTTGATGACTGCCAGCCC 
E131Q Forward GCAGTCATCGACTGGCAGGCATGGCGCCCAC 
E131Q Reverse GTGGGCGCCATGCCTGCCAGTCGATGACTGC 
Y202F Forward GGCCTCTGGGGCTTCTTTGGCTTCCCTGACT 
Y202F Reverse AGTCAGGGAAGCCAAAGAAGCCCCAGAGGCC 
S245A Forward CGTGCCCTCTATCCCGCCATCTACATGCCCG 
S245A Reverse CGGGCATGTAGATGGCGGGATAGAGGGCACG 
Y247F Forward CTCTATCCCAGCATCTTCATGCCCGCAGTGC 
Y247F Reverse GCACTGCGGGCATGAAGATGCTGGGATAGAG 
R265L Forward ATGTATGTGCAACACCTTGTGGCCGAGGCAT 
R265L Reverse ATGCCTCGGCCACAAGGTGTTGCACATACAT 
N216A Forward CTATGACTTTCTAGGCCCCGCCTACACCGGCCAGTGC 
N216A Reverse GCACTGGCCGGTGTAGGCGGGGCCTAGAAAGTCATAG 
N350A Forward TACACTGGGGCCCTTCATCCTGGCCGTGACCAGTGGGGC 
N350A Reverse GCCCCACTGGTCACGGCCAGGATGAAGGGCCCCAGTGTA 
N350tr Forward GGGCCCTTCATCCTGTAGGTGACCAGTGGGGCC 
N350tr Reverse GGCCCCACTGGTCACCTACAGGATGAAGGGCCC 
L356tr Forward GTGACCAGTGGGGCCTGACTCTGCAGTCAAGCC 
L356tr Reverse GGCTTGACTGCAGAGTCAGGCCCCACTGGTCAC 
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